Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex
- 1 November 2015
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 217, 235-242
Abstract
No abstract availableKeywords
Funding Information
- Cunningham Trust (ACC/KWF/CT04)
- Wellcome Trust (ME0442)
This publication has 28 references indexed in Scilit:
- Applications of Dendrimers for Brain Delivery and Cancer TherapyNanomedicine, 2014
- Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brainJournal of Controlled Release, 2014
- Transferrin and the Transferrin Receptor for the Targeted Delivery of Therapeutic Agents to the Brain and Cancer CellsTherapeutic Delivery, 2013
- Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseasesNeurobiology of Disease, 2010
- Drug Targeting to the BrainPharmaceutical Research, 2007
- Delivery of therapeutic agents to the central nervous system: the problems and the possibilitiesPharmacology & Therapeutics, 2004
- Gene therapy of the brainNeurology, 2004
- Brain Drug Targeting and Gene TechnologiesThe Japanese Journal of Pharmacology, 2001
- Structure and biological actions of lactoferrinJournal of Mammary Gland Biology and Neoplasia, 1996
- Transferrin receptor on endothelium of brain capillariesNature, 1984